Navigation Links
Lung cancer survivors experience long-term effects of breathlessness
Date:8/2/2010

With the growing number of long-term lung cancer survivors, research is needed to identify and address cancer survivorship issues. One of the most common and debilitating symptoms among lung cancer patients is dyspnea, or shortness of breath. As most studies of dyspnea have reviewed patients with active lung cancer or immediately after treatment, the prevalence of dyspnea over the long-term once treatment has been completed is not well characterized.

In a study featured in the August edition of the Journal of Thoracic Oncology, Marc B. Feinstein, MD describes the prevalence and severity of dyspnea in long-term lung cancer survivors and provides specific factors associated with the condition that may help clinicians target post-treatment rehabilitation strategies. Dr. Feinstein and fellow researchers at Memorial Sloan-Kettering Cancer Center and UMDNJ-Robert Wood Johnson Medical School surveyed 342 early-stage lung cancer survivors, who had their tumor removed within one to six years of the survey. Within this population of cancer survivors, dypsnea was found in 205 individuals (60 percent), nearly three-fold the number of patients who presented with dyspnea before their surgery (21 percent).

Additional findings showed that factors associated with long-term dyspnea in cancer survivors included presence of dyspnea before lung cancer surgery, reduced diffusion capacity (lung's ability to transfer oxygen into the blood) and lack of physical activity. Depression symptoms also were assessed, but were not very prevalent in the study sample (occurring among 10 percent of lung cancer survivors), but were nonetheless strongly associated with dyspnea.

"The identification of potentially modifiable risk factors associated with dyspnea is perhaps the most significant finding," affirms Marc Feinstein, MD, assistant attending physician in the Pulmonary Service at Memorial Sloan-Kettering Cancer Center. "This implies that strategies which im
'/>"/>

Contact: Megan Richter
mrichter@spectrumscience.com
202-587-2556
International Association for the Study of Lung Cancer
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Research defines timeframes, factors to deem early stage lung cancer cured
2. Vaccine Shows Some Promise Against Advanced Cancers
3. Socioeconomic status predicts survival of Canadian cancer patients
4. Certain meat components may increase bladder cancer risk
5. Snake venom studies yield insights for development of therapies for heart disease and cancer
6. Breast Cancers DNA Yields More Secrets
7. UCLA scientists for the first time identify a cell-of-origin for human prostate cancer
8. A new ground zero for prostate cancer
9. Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling
10. Vaccine Boosts Survival for Men With Advanced Prostate Cancer: Study
11. Dense bones linked to raised risk for prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... October 31, 2014 Springboard Biodiesel, ... its small scale BioPro™ biodiesel processors, announced on ... further improve the performance and efficiency of small-scale ... GL95/MC12/BD380 trio will recover more than 99% ... with the glycerin by-product produced while making biodiesel. ...
(Date:10/31/2014)... The Prevention Research Center for Healthy Neighborhoods (PRCHN) ... is a key player in nearly $13.32 million ... in Northeast Ohio. , The Centers for Disease ... for $4.35 million over five years. The funds ... testing, and disseminating individual, environmental, and policy interventions ...
(Date:10/31/2014)... Denver, Colorado (PRWEB) October 31, 2014 The ... program was created by Alexander Lynch, whose father suffered from ... through a dramatic moment, caused by his father's disease. His ... crisis. That was the crucial moment when the author of ... help his dad. , The Memory Healer program is ...
(Date:10/31/2014)... October 31, 2014 Monica Williams-Murphy ... knows all too well the chaos that can occur ... end-of-life. “The vast majority of Americans who come into ... lives are completely unprepared for the moment and so ... app can serve as a catalyst for a family ...
(Date:10/31/2014)... 2014 At the start of 2014, ... escaping carbon monoxide poisoning in their homes. Now, as ... one family-owned, Missouri-based heating and cooling company is taking ... families start the home heating season with the assurance ... , Beginning Nov. 1, 2014, E and Q Heating ...
Breaking Medicine News(10 mins):Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 2Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 3Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 3Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 3Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3
... antidepressant plus naltrexone improves odds of not drinking, researchers ... treatment with the antidepressant Zoloft (sertraline) and the alcoholism ... major depression and alcohol dependence will be able to ... of 170 patients found that 54 percent of those ...
... microarray analysis detects more abnormalities , MONDAY, March ... test is better at detecting abnormalities that predispose a ... has determined. , Researchers offered about 933 people aged ... with an autism spectrum disorder three genetic tests: G-banded ...
... ... their own Trillion Dollar Question: How do we increase employee productivity and decrease ... maker of Sweat365.com, unveils “The Healthy Corp” a breakthrough product that RE-DEFINES “Corporate ... ...
... HONG KONG , March ... or "the Group"; Stock Code: 801), China,s ... announce,today that the Group,s shareholders (the "Shareholders") have approved ... special resolution as,proposed by the board of directors ("the ...
... has named Fred Hassan as chairman of the Board of Directors and has named Brent Saunders as chief executive officer and appointed him to the Board of Directors, ... , ... ... ...
... Food and Chemical Sensitivity , announced that Philip Voluck has joined the firm and is establishing a new company that will be known as PreviMedica Lifestyle Medicine ... ... ... ...
Cached Medicine News:Health News:Newer Genetic Test for Autism More Effective 2Health News:Newer Genetic Test for Autism More Effective 3Health News:Konamoxt, Inc. Redefines Corporate Wellness with The Healthy Corp, a Customizable Corporate Wellness Platform 2Health News:Konamoxt, Inc. Redefines Corporate Wellness with The Healthy Corp, a Customizable Corporate Wellness Platform 3Health News:Golden Meditech Shareholders Approves of Name Change 2Health News:Golden Meditech Shareholders Approves of Name Change 3Health News:Bausch + Lomb Names Fred Hassan as Chairman, Brent Saunders as Chief Executive Officer 2Health News:Bausch + Lomb Names Fred Hassan as Chairman, Brent Saunders as Chief Executive Officer 3Health News:Bausch + Lomb Names Fred Hassan as Chairman, Brent Saunders as Chief Executive Officer 4Health News:Cell Science Systems Recruits Seasoned Executive to Head New Lifestyle Medicine & Nutritional Solution for Health Care Professionals 2Health News:Cell Science Systems Recruits Seasoned Executive to Head New Lifestyle Medicine & Nutritional Solution for Health Care Professionals 3Health News:Cell Science Systems Recruits Seasoned Executive to Head New Lifestyle Medicine & Nutritional Solution for Health Care Professionals 4
(Date:10/31/2014)... , Oct. 31, 2014  Australian biopharmaceutical company ... ® (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine, ... for patients with metastatic pancreatic cancer from 1 November. ... pancreatic cancer is the 5 th most common ... of all cancer deaths, with the lowest 5-year survival ...
(Date:10/31/2014)... 31, 2014 Investor-Edge has initiated ... NSPH ), Isis Pharmaceuticals Inc. (NASDAQ: ... ), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ), ... these five companies can be accessed at: http://investor-edge.com/register ... NASDAQ Composite ended at 4,566.14, up 0.37%, the Dow ...
(Date:10/31/2014)... Australia and BARCELONA , October ... Ltd (Multigate) was found to infringe two Australian patents of ... for sale in Australia safety IV ... 17.10.14 in Federal Court of Australia ... http://www.austlii.edu.au/au/cases/cth/FCA/2014/1110.html . In the detailed judgment, ...
Breaking Medicine Technology:Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 3Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 4Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 5Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 6Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 7Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 8Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L. 2
... Suture ENDO CLIP 5 mm clip ... applier is designed for introduction and ... Suture trocar sleeve, or larger with ... overall length of the shaft is ...
... Lock Clip is designed with opposing male/female ... clip retention and improved hemostasis., ,By ... a 20 percent greater angle allowing for ... ,The Reflex® ELC has an automatic, direct ...
Insert only, Pilling-Weck medium clip size...
Pilling-Weck, medium clip size, 10mm, rotatable take apart...
Medicine Products: